Adaptimmune Therapeutics PLC (ADAP)
0.6616
+0.02
(+3.93%)
USD |
NASDAQ |
Nov 22, 16:00
0.66
0.00 (0.00%)
After-Hours: 20:00
Adaptimmune Therapeutics Market Cap: 169.29M for Nov. 22, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 22, 2024 | 169.29M |
| November 21, 2024 | 162.90M |
| November 20, 2024 | 170.09M |
| November 19, 2024 | 172.67M |
| November 18, 2024 | 152.25M |
| November 15, 2024 | 150.10M |
| November 14, 2024 | 151.28M |
| November 13, 2024 | 197.18M |
| November 12, 2024 | 203.09M |
| November 11, 2024 | 210.82M |
| November 08, 2024 | 203.86M |
| November 07, 2024 | 198.74M |
| November 06, 2024 | 211.69M |
| November 05, 2024 | 212.33M |
| November 04, 2024 | 211.69M |
| November 01, 2024 | 204.60M |
| October 31, 2024 | 185.62M |
| October 30, 2024 | 178.25M |
| October 29, 2024 | 180.22M |
| October 28, 2024 | 188.59M |
| October 25, 2024 | 188.66M |
| October 24, 2024 | 191.86M |
| October 23, 2024 | 200.79M |
| October 22, 2024 | 207.21M |
| October 21, 2024 | 210.74M |
| Date | Value |
|---|---|
| October 18, 2024 | 215.58M |
| October 17, 2024 | 215.27M |
| October 16, 2024 | 222.81M |
| October 15, 2024 | 225.12M |
| October 14, 2024 | 224.89M |
| October 11, 2024 | 222.97M |
| October 10, 2024 | 224.86M |
| October 09, 2024 | 227.60M |
| October 08, 2024 | 232.48M |
| October 07, 2024 | 232.79M |
| October 04, 2024 | 243.28M |
| October 03, 2024 | 228.95M |
| October 02, 2024 | 223.76M |
| October 01, 2024 | 235.71M |
| September 30, 2024 | 243.13M |
| September 27, 2024 | 249.91M |
| September 26, 2024 | 239.63M |
| September 25, 2024 | 235.11M |
| September 24, 2024 | 248.33M |
| September 23, 2024 | 239.91M |
| September 20, 2024 | 254.75M |
| September 19, 2024 | 258.30M |
| September 18, 2024 | 265.98M |
| September 17, 2024 | 268.53M |
| September 16, 2024 | 268.53M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
92.55M
Minimum
Nov 25 2019
1.750B
Maximum
Jun 04 2020
482.47M
Average
330.36M
Median
Market Cap Benchmarks
| Biodexa Pharmaceuticals PLC | 2.654M |
| NuCana PLC | 2.763M |
| Autolus Therapeutics PLC | 782.40M |
| TC BioPharm (Holdings) PLC | 0.3085M |
| Verona Pharma PLC | 3.176B |
Market Cap Related Metrics
| PS Ratio | 0.9307 |
| Price to Book Value | 2.116 |
| Price | 0.6616 |
| Earnings Yield | -27.21% |